Is Spravato Covered by Insurance? How Coverage Actually Works
Cost is often the first practical question after "is this treatment right for me" — before you commit to an evaluation, here's how Spravato insurance coverage actually works: what insurers look for, how prior authorization works, and what happens if a claim gets denied.
For most patients, "is Spravato covered by insurance" isn't a small question — it's often the difference between starting treatment and putting it off. The honest answer is: usually, yes, when specific clinical criteria are met, but "usually" isn't "automatically," and it's worth understanding how coverage actually works before your first evaluation rather than being surprised by it afterward.
Because Spravato is FDA-approved specifically for treatment-resistant depression, its approval criteria and most insurers' coverage criteria are, by design, nearly the same thing. That overlap works in your favor, but it doesn't remove the paperwork: prior authorization is standard, processing takes time, and coverage specifics vary genuinely by plan. This guide covers what insurers look for, how prior authorization works, what it costs with and without coverage, and what to do if a claim gets denied.
What has to be true for insurance to cover Spravato?
Spravato is FDA-approved for adults with treatment-resistant depression — a specific clinical definition, not a general sense that antidepressants "haven't really worked." The standard definition, used both in Spravato's own FDA approval trials and by most insurers reviewing a coverage request, is a lack of adequate response to at least two different oral antidepressants, from different classes, each given at an adequate dose for an adequate duration (typically at least 6–8 weeks) within the current depressive episode.
That two-trial threshold isn't arbitrary. The NIMH-funded STAR*D trial (Rush et al., 2006, American Journal of Psychiatry) — the largest real-world antidepressant effectiveness study ever conducted — found that remission rates dropped substantially with each successive medication trial: roughly a third of patients reached remission on their first medication, with meaningfully lower odds on each attempt after that. That's a big part of why "two failed trials" became the clinically meaningful line for defining treatment resistance, and why it's also where most insurers draw their own coverage criteria. Spravato is separately FDA-approved for adults with major depressive disorder experiencing acute suicidal ideation or behavior, which most insurers treat as its own qualifying pathway alongside standard treatment-resistant depression.
What insurers typically want to see
Four things, consistently, across nearly every plan we work with.
Documented Trial History
Records showing at least two antidepressants, from different classes, each tried at an adequate dose for roughly 6–8 weeks without adequate relief.
Current Diagnosis Criteria
An active major depressive disorder diagnosis matching the FDA-approved indication, documented by your prescriber.
A Formal Prior Authorization
Your prescriber submits clinical documentation to your insurer before treatment starts — standard for Spravato, not a red flag specific to your case.
A REMS-Certified Site of Care
Coverage assumes treatment happens at a certified location following the federal monitoring protocol — which is every MyPremierMD office offering Spravato.
What is prior authorization, and how long does it take?
Prior authorization (PA) is your insurer's formal review of your prescriber's documentation before agreeing to cover a treatment — standard practice for a specialty medication like Spravato, not a sign your case is in question. Your prescriber submits your treatment history, current diagnosis, and clinical rationale, and the insurer reviews it against their coverage policy for esketamine.
In our team's experience handling this paperwork across thousands of Spravato patients, authorization typically comes back within 24–48 hours once a complete request is submitted. That's a typical timeline, not a guarantee — some plans move faster, some take longer, and an incomplete submission (missing dates, unclear dosing history) is the most common reason for delay. This is also exactly the kind of process where having a team that handles PA paperwork routinely, rather than doing it once, meaningfully speeds things up: knowing what a specific payer wants to see up front avoids the back-and-forth that stretches out a request.
Which insurance plans cover Spravato?
Nearly all major insurance plans provide some coverage pathway for Spravato when clinical criteria are met, including Medicare and Medicaid — across more than 30,000 treatments administered at our NJ locations, that's been true for the overwhelming majority of patients we've worked with. That said, "nearly all" genuinely isn't "all," and coverage specifics are plan-specific: your copay, whether step therapy is required first, and exactly what documentation satisfies your insurer's PA request can all vary between a Horizon BCBS plan and an Aetna plan, or between two different employer plans from the same carrier.
This is one of the clearest places where verifying your specific benefits before your first visit is worth the extra step rather than assuming. Our intake process includes an optional insurance verification — we can check your specific plan's Spravato coverage before you come in, rather than you finding out at the equivalent of a pharmacy counter for an in-office treatment.
What does Spravato actually cost, with and without insurance?
With insurance and an approved prior authorization, most patients pay between $0 and $40 per session — $0 for many Medicaid patients, with most other approved plans landing somewhere in that range depending on your specific copay or coinsurance structure. Since treatment starts at twice weekly for the first month, then steps down to weekly and eventually a maintenance interval, your total out-of-pocket cost is really a function of your per-session copay multiplied by a tapering schedule, not a single flat fee.
Without insurance coverage, cash-pay cost per session is substantial, and since a full induction month means eight or more sessions, the total adds up quickly if you're paying entirely out of pocket. If cost is a barrier even after insurance, or while a prior authorization is still pending, our team has extensive experience helping patients enroll in the manufacturer's patient assistance program, which can meaningfully reduce or eliminate the out-of-pocket cost for qualifying patients. You're not expected to just absorb the full price while paperwork works itself out.
Let's find out what your plan actually covers.
Confidential evaluations, in person or by telemedicine, typically available within 24-48 hours. Insurance verification is part of the process, not an extra step.
Why navigating insurance shouldn't be something you do alone
Prior authorization paperwork, appeals, plan-specific documentation requirements — none of it is something you should have to become an expert in on your own, on top of managing depression itself. This is exactly the kind of decision-adjacent burden that a close, accessible relationship with your care team is built to absorb rather than leave entirely on you.
In practice, that means our team handles the prior authorization submission directly rather than handing you a form to figure out, verifies your specific benefits before your first visit if you want that (there's a simple checkbox for it when you reach out), and stays reachable if a question comes up mid-process — not just at your intake appointment. Insurance navigation is rarely a single conversation; it's usually a few, spread over days or weeks, and having a team you can actually get back in touch with matters here as much as it does for a clinical question.
What happens if insurance denies coverage?
Denials do happen, and it's more honest to say so plainly than to pretend prior authorization is a formality. The most common reasons are incomplete documentation (missing exact dates or doses for prior antidepressant trials), a payer's internal policy requiring a specific step-therapy sequence that wasn't followed, or a diagnosis code that doesn't clearly match the payer's coverage policy.
A denial isn't the end of the process. Most plans allow a formal appeal, which typically involves resubmitting more complete documentation, and many payers offer a peer-to-peer review, where your prescriber speaks directly with the insurer's reviewing clinician to make the clinical case. This is exactly where experience matters: a team that has been through this specific appeal process many times, across many payers, generally has a much better sense of what a given denial actually needs to be overturned than a patient navigating it once, alone, for the first time.
How does Spravato's coverage compare to ketamine clinic costs?
This is one of the more concrete practical differences between the two, and it's covered in full in our Spravato vs. ketamine comparison. Briefly: because generic ketamine therapy is used off-label for depression, it generally isn't eligible for the same insurance coverage pathway Spravato has as an FDA-approved treatment — most ketamine clinics operate cash-pay, without a prior authorization option. If cost and insurance eligibility are significant factors in your decision, that's a meaningful, concrete difference worth weighing alongside the clinical similarities between the two, which we cover along with the real side effects both share in our Spravato side effects guide.
Keep reading about Spravato
Spravato Treatment at MyPremierMD
The full program: what to expect, our track record across 4 NJ locations, and how to get evaluated.
Learn moreSpravato Side Effects
What's expected, what's monitored, and what the FDA's black-box warning actually covers.
Learn moreSpravato vs. Ketamine
How esketamine and generic ketamine actually differ — chemically, legally, and in what your insurance will touch.
Learn moreSpravato insurance coverage: questions patients ask
Is Spravato covered by insurance?
Usually, yes, when specific clinical criteria are met — nearly all major insurance plans, including Medicare and Medicaid, provide some coverage pathway for Spravato. Coverage isn't automatic, though: it requires documentation that you meet the FDA-approved criteria for treatment-resistant depression (or major depressive disorder with acute suicidal ideation) and an approved prior authorization request.
What counts as "treatment-resistant depression" for insurance purposes?
The standard clinical definition — used both in Spravato's FDA approval trials and by most insurers — is a lack of adequate response to at least two different oral antidepressants, from different classes, each given at an adequate dose for roughly 6–8 weeks within your current depressive episode. This two-trial threshold is grounded in research showing remission odds drop substantially with each successive medication tried.
How long does Spravato prior authorization take?
In our team's experience handling this paperwork routinely, authorization typically comes back within 24–48 hours once a complete request is submitted. That's a typical timeline, not a guarantee — processing time varies by payer, and an incomplete submission is the most common reason for delay.
What happens if my insurance denies Spravato coverage?
Denials do happen, most often from incomplete documentation of prior antidepressant trials, an unmet step-therapy requirement, or a diagnosis code mismatch. A denial isn't final — most plans allow a formal appeal with more complete documentation, and many payers offer a peer-to-peer review where your prescriber discusses your case directly with the insurer's reviewing clinician.
How much does Spravato cost without insurance?
Cash-pay cost per session is substantial, and since a full induction month means eight or more sessions, the total adds up quickly without coverage. With an approved prior authorization, most patients instead pay between $0 (many Medicaid patients) and $40 per session. If cost remains a barrier, our team has extensive experience helping patients enroll in the manufacturer's patient assistance program.
Does Medicare cover Spravato?
Generally, yes, when you meet the same treatment-resistant depression or acute-suicidal-ideation criteria required for other coverage, and prior authorization is approved. Across more than 30,000 treatments administered at our NJ locations, Medicare coverage has been consistent for patients who meet criteria, though your specific plan's process should still be verified individually.
Will I need to try other treatments before insurance covers Spravato?
Yes — this is built into the FDA-approved indication itself, not an insurance-specific hurdle. Spravato is approved for treatment-resistant depression, defined as inadequate response to at least two prior antidepressant trials at adequate dose and duration, so documenting that history is a required part of both the clinical picture and the coverage request.
Does MyPremierMD help with the insurance process?
Yes. Our team handles prior authorization submissions directly, offers optional insurance verification before your first visit, and stays reachable if questions come up mid-process rather than only at intake. Insurance navigation is usually a few conversations spread over time, not one, and you're not expected to manage it alone.
Contact MyPremierMD Today
We'll reach out within 24 hours to answer your questions and help you schedule an appointment.